Bicara Therapeutics Inc. share price logo

Bicara Therapeutics Inc.

NASDAQ: BCAX

Small Cap

$23.57

-0.33

(-1.38%)

as on

Bicara Therapeutics Inc. Stock Performance

as on August 25, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $22.94
    $24.23
    downward going graph

    2.67%

    Downside

    2.80%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $10.30
    $30.99
    downward going graph

    56.32%

    Downside

    31.48%

    Upside

    downward going graph

Bicara Therapeutics Inc. share price movements today

Previous Close
$23.90
Open
$23.72
Volume
722.3K
Market Cap
$1.6B
Day's Low - High
$22.94 - $24.23
52 Week Low - High
$10.30 - $30.99

Bicara Therapeutics Inc. Historical Returns

1 Month Return
-12.54 %
3 Month Return
+ 20.02 %
1 Year Return
+ 108.59 %
3 Year Return
0 %
5 Year Return
0 %

Bicara Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Bicara Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.6B

EPS (TTM)

-3.1

Dividend Yield

0.00%

PE Ratio (TTM)

-7.62

Industry PE ratio

-7.283372093023256

PEG Ratio

0.1739053427142887

Return On Equity TTM

-41.49%

Bicara Therapeutics Inc. Stock Valuation

Track how Bicara Therapeutics Inc. P/E has moved over time to understand its valuation trends.

Bicara Therapeutics Inc. in the last 4 years

  • Overview

  • Trends

Lowest (-32.02x)

December 31, 2022

Industry (-7.28x)

December 31, 2025

Today (-6.68x)

December 31, 2025

Highest (-6.68x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -6.68x

Bicara Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bicara Therapeutics Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$1.6BNA-7.620.00%NA
BUY$43.7B669.3%NA0.00%NA
BUY$128.2B154.86%29.8286.04%NA
BUY$25.3B-84.24%-7.98-12.57%NA
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for Bicara Therapeutics Inc. Stock including INR - Dollar returns

The Bicara Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Bicara Therapeutics Inc. investment value today

Current value as on today

₹2,21,274

Returns

₹1,21,274

(+121.27%)

Returns from Bicara Therapeutics Inc. Stock

₹1,02,491 (+102.49%)

Dollar Impact

₹18,783 (+18.78%)

Analyst Recommendation on Bicara Therapeutics Inc. Stock

Based on 11 analysts

BUY

72.73%

Buy

27.27%

Hold

0.00%

Sell

Based on 11 analysts, 72.72727272727273% of analysts recommend a 'BUY' rating for Bicara Therapeutics Inc.. Average target price of $33.18

Indian Investors' Interest in Bicara Therapeutics Inc. Stock

Search interest for Bicara Therapeutics Inc. Stock has decreased by -19% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-19% versus previous 30 day period

Bicara Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-15
-19
-20
-26
-41
-32
-40
-41
-60
-59
EBITDA
-12
-17
-17
-20
-36
-27
-36
-37
-56
-54
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-12
-17
-17
-20
-36
-27
-36
-37
-56
-55
Income Tax Expense
0
-
-
0
0
0
0
0
0
0
Net Income
-12
-17
-17
-20
-36
-27
-36
-37
-56
-55
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Bicara Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Income
-37
-39
-82
-155
EBITDA
-37
-51
-67
-137
Interest Expense
0
-
-
-
Depreciation
0
0
0
0
Income Before Tax
-37
-51
-67
-137
Income Tax Expense
0
0
0
0
Net Income
-37
-51
-67
-137
Net Profit Margin
0.00%
0.00%
0.00%
0.00%

Bicara Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-12
-17
-17
-20
-36
-27
-36
-37
-56
-55
Operating Cash Flow
-14
-12
-17
-30
-28
-25
-29
-23
-37
-44
Investing Cash Flow
0
0
0
0
-
-
-236
-82
100
-184
Financing Cash Flow
0
0
334
0
0
0
0
31
163
2
Change in Cash
-14
203
316
-31
-27
-25
-264
-74
226
-226

Bicara Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-37
-51
-67
-137
Operating Cash Flow
-32
-45
-74
-106
Investing Cash Flow
0
0
0
-318
Financing Cash Flow
31
272
334
32
Change in Cash
0
226
259
-393

Mutual Funds that own Bicara Therapeutics Inc. Stock

Check out the Mutual Funds with significant holdings in Bicara Therapeutics Inc..

Funds
Holdings
Shares Held
T. ROWE PRICE SMALL-CAP STOCK FUND, INC.
3.320495%
2181694
VANGUARD INDEX FUNDS
2.62928%
1727539
T. Rowe Price Equity Funds, Inc.
1.820801%
1196337
Fidelity Select Portfolios
1.438119%
944900
Franklin Strategic Series
1.35834%
892482

Global Institutional Holdings in Bicara Therapeutics Inc.

Funds
Holdings
Peter Kolchinsky
11.04%
Vanguard
3.95%
Otello Stampacchia
3.64%
iShares
3.07%
SPDR
1.94%

Insights on Bicara Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, BCAX stock has moved up by 111.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 487.2% return, outperforming this stock by 376.1%

About Bicara Therapeutics Inc.

Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody bound to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.
OrganisationBicara Therapeutics Inc.
Headquarters116 Huntington Avenue, Boston, MA, United States, 02116
IndustryBiotechnology
CEODr. Claire Mazumdar Clemon M.B.A., Ph.D.
E-voting on sharesClick here to vote

Key Management of Bicara Therapeutics Inc.

Name

Title

Mr. Ivan Hyep M.B.A.

CFO & Treasurer

Ms. Lara S. Meisner J.D.

Chief Legal Officer, Compliance Officer & Corporate Secretary

Ms. Rachel Salazar

SVP of R&D Strategy and Operations

Ms. Angela Windt

VP & Head of Regulatory Affairs

Dr. Jeltje Schulten M.B.A., M.D.

Senior Vice President of Clinical & Medical Affairs

Dr. Claire Mazumdar Clemon M.B.A., Ph.D.

CEO & Director

Mr. Ryan Cohlhepp Pharm.D.

President, COO & Director

Ms. Rachel Frank

Vice President of Investor Relations and Corporate Communications

Ms. Pauline Dufresne

Chief People Officer

Ms. Sathish Hasige Ph.D.

Senior VP and Head of Technical Operations & Supply Chain

FAQs

What is Bicara Therapeutics Inc. share price today?

Bicara Therapeutics Inc. share price today is $23.57 as on at the close of the market. Bicara Therapeutics Inc. share today touched a day high of $24.23 and a low of $22.94.

What is the 52 week high and 52 week low for Bicara Therapeutics Inc. share?

Bicara Therapeutics Inc. share touched a 52 week high of $30.99 on and a 52 week low of $10.30 on . Bicara Therapeutics Inc. stock price today i.e. is closed at $23.57,which is 23.94% down from its 52 week high and 128.95% up from its 52 week low.

What is Bicara Therapeutics Inc.'s market capitalisation today?

Bicara Therapeutics Inc. market capitalisation is $0.00T as on .

How to invest in Bicara Therapeutics Inc. Stock (BCAX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bicara Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bicara Therapeutics Inc. Shares that will get you 0.0636 shares as per Bicara Therapeutics Inc. share price of $23.57 per share as on August 25, 2026 at 1:29 am IST.

What is the minimum amount required to buy Bicara Therapeutics Inc. Stock (BCAX) from India?

Indian investors can start investing in Bicara Therapeutics Inc. (BCAX) shares with as little as ₹95.735 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.35 in Bicara Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Bicara Therapeutics Inc. share’s latest price of $23.57 as on August 25, 2026 at 1:29 am IST, you will get 0.4243 shares of Bicara Therapeutics Inc.. Learn more about fractional shares .